Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Use of Raw Materials in GMP Batches – V 2.0

Posted on By


Biosimilars: SOP for Use of Raw Materials in GMP Batches – V 2.0


Standard Operating Procedure for Use of Raw Materials in GMP Batches in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/146/2025
Supersedes SOP/BS/146/2022
Page No. Page 1 of 10
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define the procedure for the qualification, handling, approval, and traceable usage of raw materials in GMP batches used in the biosimilar manufacturing process, ensuring regulatory compliance and product quality.

2. Scope

This SOP applies to all raw materials including media components, salts, buffers, and excipients used in GMP-grade biosimilar batches within the manufacturing facility.

3. Responsibilities

  • Warehouse: Receive, store, and issue approved raw materials with appropriate labeling and documentation.
  • QC: Sample and test each material against specifications.
  • QA: Review COA, approve raw material release, and monitor traceability.
  • Production: Use only released materials, verify lot numbers, and record usage in batch records.

4. Accountability

The QA Head is accountable for the approval and traceability of raw materials in GMP production batches and ensuring their use complies with approved procedures and specifications.

5. Procedure

5.1 Raw Material Receipt and Sampling

  1. Receive raw materials with invoice, COA, and MSDS at warehouse receiving bay.
  2. Assign internal material code and quarantine status label.
  3. QC to sample material under controlled conditions and document in Annexure-1: Sampling Log.

5.2 Material Testing and Approval

  1. QC to perform tests including:
    • Identity (IR, NMR, TLC)
    • Purity and assay
    • pH and appearance
    • Microbial limits (if applicable)
  2. QA reviews results and releases the material with “Approved” status label and assigns release number.

5.3 Material Dispensing and Traceability

  1. Materials for GMP batches to be dispensed in classified areas under LAF units.
  2. Record each dispensation in Annexure-2: Material Dispensing Log, capturing:
    • Batch number
    • Material code and name
    • Quantity dispensed
    • Lot number
    • Person dispensing
  3. Weighing equipment must be calibrated and cleaned before use.

5.4 Usage in Production

  1. Production to verify the material label, status, lot number, and expiry before use.
  2. Cross-check against the BMR (Batch Manufacturing Record).
  3. Record actual quantity used and reconcile with dispensed quantity.

5.5 Material Rejection or Deviation Handling

  1. Any material found out of specification shall be quarantined and investigated by QA.
  2. Rejection must be documented in Annexure-3: Rejected Material Log.

5.6 Storage and Expiry Monitoring

  1. All materials to be stored as per label conditions (e.g., RT, 2–8°C, desiccated).
  2. Warehouse to maintain Annexure-4: Material Expiry Monitoring Log and alert QA 30 days before expiry.

6. Abbreviations

  • GMP: Good Manufacturing Practice
  • QA: Quality Assurance
  • QC: Quality Control
  • BMR: Batch Manufacturing Record
  • LAF: Laminar Air Flow

7. Documents

  1. Sampling Log – Annexure-1
  2. Material Dispensing Log – Annexure-2
  3. Rejected Material Log – Annexure-3
  4. Material Expiry Monitoring Log – Annexure-4

8. References

  • EU GMP Part I – Chapter 5: Production
  • WHO TRS 986 – Annex 2: GMP for Biologics
  • ICH Q7 – GMP for Active Pharmaceutical Ingredients

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Sampling Log

Date Material Name Code Batch No. Sampled By Container Count
02/05/2025 Sodium Bicarbonate RM-091 SB-50025 Ajay Verma 4

Annexure-2: Material Dispensing Log

Date Batch No. Material Code Qty Lot No. Dispensed By
03/05/2025 BS-UP-097 Glucose Monohydrate RM-112 1.0 kg GM-7782 Sunita Reddy

Annexure-3: Rejected Material Log

Date Material Code Reason Rejected By
01/05/2025 Sodium Chloride RM-102 pH out of range QA Officer

Annexure-4: Material Expiry Monitoring Log

Material Lot No. Expiry Date Alert Sent Action Taken
L-Glutamine LG-2098 15/06/2025 15/05/2025 To be used by 10/06/2025

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Expanded traceability and expiry control procedures GMP Compliance Enhancement
See also  Biosimilars: SOP for Audit Readiness of CLD Documentation - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Gel Manufacturing: SOP for Monitoring Environmental Conditions in Gel Manufacturing Areas – V 2.0
Next Post: Analytical Method Development: SOP for Identification of Unknown Degradation Products – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version